NOAEL Studies Cosmetic Ingredient

Capramide DEA NOAEL Studies

INCI: CAPRAMIDE DEA

CAS: 136-26-5

Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.

Back to parent ingredient page
CIR Safety Assessment 5 endpoints
Source Endpoint Type Value Unit Species Route Duration Study Type Reference
CIR Safety Assessment NOAEL =0.1 % rat oral 13-week repeated dose toxicity 100; 400; 3, p.20
CIR Safety Assessment NOAEL =200 mg/kg/d rat oral 4 weeks developmental toxicity 4; 350; 380, p.14
CIR Safety Assessment NOAEL =380 mg/kg/d rat oral 4 weeks developmental toxicity 20; 320; 6, p.14
CIR Safety Assessment NOAEL =1000 mg/kg/d rat oral 13-week repeated dose toxicity 100; 400; 3, p.20
CIR Safety Assessment NOAEL =5000 ppm rat oral 13-week repeated dose toxicity 100; 400; 3, p.20
Regulatory source 5 endpoints
Source Endpoint Type Value Unit Species Route Duration Study Type Reference
Regulatory source developmental toxicity 200 mg/kg/d rat oral 4 weeks developmental toxicity p.14
Regulatory source developmental toxicity 380 mg/kg/d rat oral 4 weeks developmental toxicity p.14
Regulatory source repeated dose toxicity 0.1 % rat oral 13-week repeated dose toxicity p.20
Regulatory source repeated dose toxicity 1000 mg/kg/d rat oral 13-week repeated dose toxicity p.20
Regulatory source repeated dose toxicity 5000 ppm rat oral 13-week repeated dose toxicity p.20
openFDA substances 1 endpoint
Source Endpoint Type Value Unit Species Route Duration Study Type Reference
openFDA substances FDA UNII substance identifier SHH19DQ1DH UNII - - - chemical -